Literature DB >> 25053413

Chemically modified N-acylated hyaluronan fragments modulate proinflammatory cytokine production by stimulated human macrophages.

Oladunni Babasola1, Karen J Rees-Milton1, Siziwe Bebe1, Jiaxi Wang2, Tassos P Anastassiades3.   

Abstract

Low molecular mass hyaluronans are known to induce inflammation. To determine the role of the acetyl groups of low molecular mass hyaluronan in stimulating the production of proinflammatory cytokines, partial N-deacetylation was carried out by hydrazinolysis. This resulted in 19.7 ± 3.5% free NH2 functional groups, which were then acylated by reacting with an acyl anhydride, including acetic anhydride. Hydrazinolysis resulted in bond cleavage of the hyaluronan chain causing a reduction of the molecular mass to 30-214 kDa. The total NH2 and N-acetyl moieties in the reacetylated hyaluronan were 0% and 98.7 ± 1.5% respectively, whereas for butyrylated hyaluronan, the total NH2, N-acetyl, and N-butyryl moieties were 0, 82.2 ± 4.6, and 22.7 ± 3.8%, respectively, based on (1)H NMR. We studied the effect of these polymers on cytokine production by cultured human macrophages (THP-1 cells). The reacetylated hyaluronan stimulated proinflammatory cytokine production to levels similar to LPS, whereas partially deacetylated hyaluronan had no stimulatory effect, indicating the critical role of the N-acetyl groups in the stimulation of proinflammatory cytokine production. Butyrylated hyaluronan significantly reduced the stimulatory effect on cytokine production by the reacetylated hyaluronan or LPS but had no stimulatory effect of its own. The other partially N-acylated hyaluronan derivatives tested showed smaller stimulatory effects than reacetylated hyaluronan. Antibody and antagonist experiments suggest that the acetylated and partially butyrylated lower molecular mass hyaluronans exert their effects through the TLR-4 receptor system. Selectively N-butyrylated lower molecular mass hyaluronan shows promise as an example of a novel semisynthetic anti-inflammatory molecule.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  CD44; Cytokine; Glycobiology; Hyaluronan; Hyaluronate; Inflammation; Macrophage; N-Acylation; Polymers; Toll-like Receptor (TLR)

Mesh:

Substances:

Year:  2014        PMID: 25053413      PMCID: PMC4155647          DOI: 10.1074/jbc.M113.515783

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

1.  New cross-linked and sulfated derivatives of partially deacetylated hyaluronan: synthesis and preliminary characterization.

Authors:  Vittorio Crescenzi; Andrea Francescangeli; Davide Renier; Davide Bellini
Journal:  Biopolymers       Date:  2002-07-05       Impact factor: 2.505

2.  Hyaluronan inhibits Akt, leading to nuclear factor-κB down-regulation in lipopolysaccharide-stimulated U937 macrophages.

Authors:  Tadashi Yasuda
Journal:  J Pharmacol Sci       Date:  2011-03-16       Impact factor: 3.337

3.  Hyaluronan fragments act as an endogenous danger signal by engaging TLR2.

Authors:  Kara A Scheibner; Michael A Lutz; Sada Boodoo; Matthew J Fenton; Jonathan D Powell; Maureen R Horton
Journal:  J Immunol       Date:  2006-07-15       Impact factor: 5.422

4.  Hyaluronan reduces inflammation in experimental arthritis by modulating TLR-2 and TLR-4 cartilage expression.

Authors:  Giuseppe M Campo; Angela Avenoso; Giancarlo Nastasi; Antonio Micali; Vera Prestipino; Mario Vaccaro; Angela D'Ascola; Alberto Calatroni; Salvatore Campo
Journal:  Biochim Biophys Acta       Date:  2011-06-21

Review 5.  Interleukin-1β and interleukin-6 in arthritis animal models: roles in the early phase of transition from acute to chronic inflammation and relevance for human rheumatoid arthritis.

Authors:  Gianfranco Ferraccioli; Luisa Bracci-Laudiero; Stefano Alivernini; Elisa Gremese; Barbara Tolusso; Fabrizio De Benedetti
Journal:  Mol Med       Date:  2010-08-02       Impact factor: 6.354

6.  Hyaluronan in part mediates IL-1beta-induced inflammation in mouse chondrocytes by up-regulating CD44 receptors.

Authors:  Giuseppe M Campo; Angela Avenoso; Angela D'Ascola; Michele Scuruchi; Vera Prestipino; Alberto Calatroni; Salvatore Campo
Journal:  Gene       Date:  2011-12-13       Impact factor: 3.688

7.  Hydrazinolysis of heparin and other glycosaminoglycans.

Authors:  P N Shaklee; H E Conrad
Journal:  Biochem J       Date:  1984-01-01       Impact factor: 3.857

8.  A decrease in moisture absorption-retention capacity of N-deacetylation of hyaluronic acid.

Authors:  Wuxia Zhang; Haibo Mu; Amin Zhang; Guoting Cui; Hua Chen; Jinyou Duan; Shunchun Wang
Journal:  Glycoconj J       Date:  2012-12-06       Impact factor: 2.916

9.  Hyaluronan inhibits matrix metalloproteinase-1 production by rheumatoid synovial fibroblasts stimulated by proinflammatory cytokines.

Authors:  Makoto Shimizu; Tadashi Yasuda; Takefumi Nakagawa; Eizaburo Yamashita; Sohel M Julovi; Teruko Hiramitsu; Takashi Nakamura
Journal:  J Rheumatol       Date:  2003-06       Impact factor: 4.666

10.  Inhibition of interleukin-1beta-stimulated production of matrix metalloproteinases by hyaluronan via CD44 in human articular cartilage.

Authors:  Sohel M Julovi; Tadashi Yasuda; Makoto Shimizu; Teruko Hiramitsu; Takashi Nakamura
Journal:  Arthritis Rheum       Date:  2004-02
View more
  11 in total

1.  Impact of structurally modifying hyaluronic acid on CD44 interaction.

Authors:  D Bhattacharya; D Svechkarev; J J Souchek; T K Hill; M A Taylor; A Natarajan; A M Mohs
Journal:  J Mater Chem B       Date:  2017-09-20       Impact factor: 6.331

2.  N-Butyrylated Hyaluronic Acid Achieves Anti-Inflammatory Effects In Vitro and in Adjuvant-Induced Immune Activation in Rats.

Authors:  Xue Luan; Zhongcheng Cong; Tassos P Anastassiades; Yin Gao
Journal:  Molecules       Date:  2022-05-19       Impact factor: 4.927

3.  The Labeling, Visualization, and Quantification of Hyaluronan Distribution in Tumor-Bearing Mouse Using PET and MR Imaging.

Authors:  Wangxi Hai; Xiao Bao; Kang Sun; Biao Li; Jinliang Peng; Yuhong Xu
Journal:  Pharm Res       Date:  2020-11-04       Impact factor: 4.200

Review 4.  Hyaluronan interactions with innate immunity in lung biology.

Authors:  Robert M Tighe; Stavros Garantziotis
Journal:  Matrix Biol       Date:  2018-02-02       Impact factor: 11.583

Review 5.  Hyaluronan as a therapeutic target in human diseases.

Authors:  Jiurong Liang; Dianhua Jiang; Paul W Noble
Journal:  Adv Drug Deliv Rev       Date:  2015-11-02       Impact factor: 15.470

6.  Pseudomonas aeruginosa ExsA Regulates a Metalloprotease, ImpA, That Inhibits Phagocytosis of Macrophages.

Authors:  Zhenyang Tian; Sen Cheng; Bin Xia; Yongxin Jin; Fang Bai; Zhihui Cheng; Shouguang Jin; Xiaoyun Liu; Weihui Wu
Journal:  Infect Immun       Date:  2019-11-18       Impact factor: 3.441

Review 7.  Modulation of hyaluronan signaling as a therapeutic target in human disease.

Authors:  Stavros Garantziotis
Journal:  Pharmacol Ther       Date:  2021-09-26       Impact factor: 12.310

Review 8.  A Trickster in Disguise: Hyaluronan's Ambivalent Roles in the Matrix.

Authors:  Lena Bohaumilitzky; Ann-Kathrin Huber; Eva Maria Stork; Simon Wengert; Franziska Woelfl; Heike Boehm
Journal:  Front Oncol       Date:  2017-10-09       Impact factor: 6.244

Review 9.  Chemical Modification of Hyaluronan and Their Biomedical Applications.

Authors:  Vera Hintze; Matthias Schnabelrauch; Sandra Rother
Journal:  Front Chem       Date:  2022-02-11       Impact factor: 5.221

10.  iTRAQ‑based proteomic analysis of the interaction of A549 human lung epithelial cells with Aspergillus fumigatus conidia.

Authors:  Xiaowei Zhang; Dan He; Song Gao; Yunyun Wei; Li Wang
Journal:  Mol Med Rep       Date:  2020-10-11       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.